Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE)

Eberhardt, Wilfried Ernst Erich; Poettgen, Christoph; Gauler, Thomas Christoph; Friedel, Godehard; Veit, Stefanie; Heinrich, Vanessa; Welter, Stefan; Budach, Wilfried; Spengler, Werner; Kimmich, Martin; Fischer, Berthold; Schmidberger, Heinz; De Ruysscher, Dirk; Belka, Claus; Cordes, Sebastian; Hepp, Rodrigo; Luetke-Brintrup, Diana; Lehmann, Nils; Schuler, Martin; Joeckel, Karl-Heinz; Stamatis, Georgios; Stuschke, Martin

Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE)

Autor(en):

Eberhardt, Wilfried Ernst Erich; Poettgen, Christoph; Gauler, Thomas Christoph; Friedel, Godehard; Veit, Stefanie; Heinrich, Vanessa; Welter, Stefan; Budach, Wilfried; Spengler, Werner; Kimmich, Martin; Fischer, Berthold; Schmidberger, Heinz; De Ruysscher, Dirk; Belka, Claus; Cordes, Sebastian; Hepp, Rodrigo; Luetke-Brintrup, Diana; Lehmann, Nils; Schuler, Martin; Joeckel, Karl-Heinz; Stamatis, Georgios; Stuschke, Martin

Tübinger Autor(en):

Heinrich, Vanessa
Budach, Wilfried
Spengler, Werner

Erschienen in:

Journal of Clinical Oncology (2015), Bd. 33, H. 35, S. 4194-

Verlagsangabe:

Amer Soc Clinical Oncology

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1200/JCO.2015.62.6812

ISSN:

1527-7755